NRC Health Current Income Tax Expense (Benefit)
NRC Health (NRC) reported Current Income Tax Expense (Benefit) of $3.79 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2026-03-05
- NRC Health current income tax expense (benefit) for fiscal 2025 was $3.79M, a 55.76% decline from fiscal 2024.
- NRC Health current income tax expense (benefit) for fiscal 2024 was $8.57M, a 15.24% decline from fiscal 2023.
- NRC Health current income tax expense (benefit) for fiscal 2023 was $10.11M.
| Period end | Current Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $3.79M 10-K · filed 2026-03-05 |
| 2024-12-31 | $8.57M 10-K · filed 2026-03-05 |
| 2023-12-31 | $10.11M 10-K · filed 2026-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |